Rheumatrex, Methotrexate News Archives

If it's darker and more dried, it might be from further up the digestive system and needs to be checked out further.

Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis and active psoriatic arthritis .

STUDY DESIGN: A retrospective study of 38 patients with JDM treated at a tertiary care children's hospital identified 8 patients who had never received corticosteroids.

Oct 19, 2009 - Bristol-Myers Squibb Company today announced two-year results of a study that supports use of ORENCIA for methotrexate-naive patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.

Investigators are reporting that tolicizumab is an effective, long-term treatment option in multiple subgroups of rheumatoid arthritis patients.

For many people with rheumatoid arthritis , the traditional, and much cheaper, disease-modifying antirheumatic drugs appear to work just as well as newer TNF blockers that target the underlying disease process, a large study shows.

Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRAA , in combination with methotrexate, had no progression of joint damage, compared with people who received methotrexate alone ...

Phase III Study Showed Two Years Of ACTEMRA Inhibited Progression Of Joint Damage And Improved Disease Remission Main Category: Arthritis / Rheumatology Also Included In: Clinical Trials / Drug Trials Article Date: 20 Oct 2009 Genentech, Inc., a wholly-owned member of the Roche Group , announced two-year results from a Phase III study, which ...

Bristol-Myers Squibb says new findings support further development of subcutaneous administration of ORENCIA in RA patients Published in M2Europharma on Tuesday, 20 October 2009 at 22:25 GMT 20 October 2009 - US-headquartered Bristol-Myers Squibb Company said today that new clinical data support continued development of a subcutaneous ...

Main Category: Arthritis / Rheumatology Also Included In: Clinical Trials / Drug Trials ; Conferences ; Pharma Industry / Biotech Industry Article Date: 20 Oct 2009 - 1:00 PDT New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis receiving SIMPONI every four weeks achieved sustained ...

A coroner has told a pharmacist who filled an incorrect prescription that led to the death of an 89-year-old woman that he is not to blame for what happened.

Rituxan is approved by the FDA to treat moderate-to-severe rheumatoid arthritis in patients who have had an inadequate response to methotrexate and one or more TNF blockers .

Genentech, Inc., a wholly-owned member of the Roche Group , today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA , in combination with methotrexate, had no progression of joint damage, compared with people who received methotrexate alone ...

In the first and largest researcher-initiated blinded study comparing the effectiveness of a drug treatment for rheumatoid arthritis, researchers found a $1,000 treatment and a $25,000 treatment to have the same effectiveness.

The Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc.

Rheumatoid Arthritis Home > Questions > With RA and a suppressed immune system , how does the flu shot work? Receive a FREE Osteoarthritis of the knee pamphlet.

Spiked: Bella Prowse claims that her lover Edward Erin poisoned her drinks with a drug to make her miscarry A doctor's mistress who accused her hospital consultant lover of spiking her drink to abort their child could have taken the drugs herself, a court heard yesterday.

A scientist today threw doubt on the "tea-poisoning" story of doctor's mistress Bella Prowse.

A new "smart" drug that can ease the agony of patients with previously untreatable rheumatoid arthritis has launched amid fears it will not be made available on the NHS.

An alternative new drug for rheumatoid athritis may help to ease the painful symptoms of 40,000 patients who do not benefit from current medications.

Bella Prowse fell pregnant after a month fling with Edward Erin that started at a Christmas party.

Cellceutix Corporation today announced that it has successfully completed a study with its proprietary compound, KM-133, in a human xenograft animal model of psoriasis.

However, studies at single institutions have suggested that 55 to 65 percent of such patients might be cured by third-generation regimens such as ones consisting of low-dose methotrexate with leucovorin rescue, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone ; prednisone, doxorubicin, cyclophosphamide, and etoposide, ...